Integramed America, Inc. (INMD) Reports In-Line Q3 EPS, Sales Increase 15% Y/Y
Tweet
Share
E-mailGet Alerts INMD Hot Sheet
Price: $15.28 +1.80%
Revenue Growth %: -3.1%
Financial Fact:
Weighted average shares - diluted (in Shares): 12.01M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: -3.1%
Financial Fact:
Weighted average shares - diluted (in Shares): 12.01M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Integramed America, Inc. (NASDAQ: INMD) reported Q3 EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $69.4 million versus the consensus estimate of $68.51 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InMode confirms unsolicited acquisition bid from Steel Partners
- Delta Air Lines Q2 earnings preview: softer profit expected amid fuel price headwinds
- PriceSmart (PSMT) Misses Q3 EPS by 4c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
